Controlled release and dura mater permeability of lidocaine and ibuprofen from injectable poloxamer-based gels

被引:89
作者
Paavola, A
Yliruusi, J
Rosenberg, P
机构
[1] Univ Helsinki, Bioctr 2, Pharmaceut Technol Div, Dept Pharm, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Anesthesiol, Helsinki, Finland
关键词
controlled release; poloxamer; 407; gel; lidocaine center dot HCl; ibuprofen Na; dural permeability;
D O I
10.1016/S0168-3659(97)00206-X
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Epidural administration of drugs is becoming more common in the treatment of severe forms of pain. To improve present therapies, a long-acting single-dose gel injection would be beneficial. The present study investigated the use of three different polymers as additives in injectable poloxamer gel in controlling the drug release. The release of lidocaine . HCl and ibuprofen Na from 25% poloxamer (PO) gel and poloxamer gel with hydroxypropylmethylcellulose (HPMC), sodium carboxymethylcellulose (CMC), or dextran (DE) was studied in vitro. Cellulose additives significantly prolonged ibuprofen release, whereas additives were found to have a slight release-increasing effect on lidocaine as compared with the PO gel. The structural differences of the gels, more than the macroviscosity, seem to regulate the release of drugs. The drug permeation-prolonging effect of the respective gels, along with the control solutions, was evaluated in vitro using porcine dura mater membrane. The compact gel depot acted as the rate-limiting step, and significantly prolonged the dural permeation of both drugs in comparison with control solutions. The difference in the drug release and permeation-reducing effects of the gels demonstrated the possibility for interactions between dural membrane and the gel. The findings are promising for further experimental in vivo animal testing of these injectable poloxamer-based gels. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 21 条
[1]  
BROMAGE PR, 1975, BRIT J ANAESTH, V47, P199
[2]  
CHENCHOW PC, 1981, INT J PHARM, V8, P89
[3]  
Chien Y W, 1981, J Parenter Sci Technol, V35, P106
[4]  
Craig P.N., 1990, Comprehensive Medicinal Chemistry, VVolume 6, P237
[5]   PROLONGATION OF LIDOCAINE-INDUCED EPIDURAL-ANESTHESIA BY MEDIUM MOLECULAR-WEIGHT HYALURONIC-ACID FORMULATIONS - PHARMACODYNAMIC AND PHARMACOKINETIC STUDIES IN THE RABBIT [J].
DOHERTY, MM ;
HUGHES, PJ ;
KORSZNIAK, NV ;
CHARMAN, WN .
ANESTHESIA AND ANALGESIA, 1995, 80 (04) :740-746
[6]   THE ANTINOCICEPTIVE EFFECTS OF PROSTAGLANDIN ANTAGONISTS IN THE RAT [J].
DROWER, EJ ;
STAPELFELD, A ;
MUELLER, RA ;
HAMMOND, DL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 133 (03) :249-256
[7]   NEUROKINETICS OF LIDOCAINE IN INFRAORBITAL NERVE OF RAT INVIVO - RELATION TO SENSORY BLOCK [J].
FINK, BR ;
AASHEIM, G ;
KISH, SJ ;
CROLEY, TS .
ANESTHESIOLOGY, 1975, 42 (06) :731-736
[8]  
Flory PJ, 1953, PRINCIPLES POLYM CHE, P576
[9]   CHARACTERIZATION OF ACRYLIC RESIN MATRIX FILMS AND MECHANISMS OF DRUG-POLYMER INTERACTIONS [J].
JENQUIN, MR ;
MCGINITY, JW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 101 (1-2) :23-34
[10]  
JOHNSTON T P, 1985, Journal of Parenteral Science and Technology, V39, P83